Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05455073
Other study ID # NI-02-2019-SNAP
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 31, 2019
Est. completion date February 28, 2022

Study information

Verified date April 2022
Source Nutrition International
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Addressing the nutrition needs of adolescents could be an important initiative for breaking the vicious cycle of intergenerational malnutrition, chronic diseases and poverty. To respond to these diverse needs of adolescents, the Government of Bangladesh (GoB) in 2012, instituted a national policy for adolescent girls' weekly iron and folic acid (WIFA) supplementation in secondary schools to reduce anemia. Efforts are in place to roll out a national WIFA supplementation program for both in-school and out-of-school adolescent girls aged 10-19 years. Responding to the need to demonstrate the feasibility of such a new initiative before it is scaled-up, Nutrition International (NI) with funding support from the Government of Canada committed to providing technical and financial support to demonstrate to the GoB, the feasibility of a school-based delivery of nutrition interventions to improve the nutrition and health status of adolescents in Joypurhat and Sirajganj districts of Bangladesh. The project developed and began roll out of a multi-sectorial holistic and integrated nutrition approach consisting of both a nutrition-specific and nutrition-sensitive program model for improving the general health and nutrition of adolescents in schools. This was delivered in an integrated package for girls and boys including WIFA supplementation (girls only), promotion of improved water, sanitation and hygiene (WASH), behavior change interventions (BCI) on all topics, and support for menstrual hygiene management (MHM) for girls, including sale of menstrual products in schools. To evaluate the program, the GoB (Institute of Public Health and Nutrition, Ministry of Health and Family Welfare (IPHN) and The Directorate of Secondary and Higher Education, Ministry of Education (DSHE) and NI with technical assistance from the CDC Foundation and CDC planned process and outcome evaluations for the first year of the program's implementation.


Description:

The outcome evaluation was a school (cluster)-based, randomized controlled trial with three equal size intervention arms, sampling adolescents, teachers, and student leaders in 75 selected schools. The study investigated the impact of the school-based program implemented in Joypurhat and aimed to examine the effectiveness and factors influencing scalability of using the secondary school platform to deliver WIFA co-packaged with WASH, MHM, and BCI to improve the nutrition and health status of adolescents in Bangladesh. The process evaluation sampled adolescents, teachers, and student leaders from 12 schools selected through convenience sampling for qualitative interviews, and determined whether the school-based program was implemented as intended, and why and how the intervention components worked to produce an impact - specifically, assessing the level of adherence.


Recruitment information / eligibility

Status Completed
Enrollment 3018
Est. completion date February 28, 2022
Est. primary completion date March 22, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 10 Years to 19 Years
Eligibility Inclusion Criteria: - Randomly selected adolescent girl or boy - Present on the day(s) of the survey - Verbal assent and parental/guardian written consent - School level headteacher, assigned teacher or student leader in the various grades Exclusion Criteria: - Girl or boy enrolled in grades other than grades 8 or 9 - Enrolled after random selection of participants

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Weekly Iron and Folic Acid Supplementation (WIFA)
Weekly school provision of WIFA tablets to adolescent girls
Combination Product:
WASH
Ensure availability (or provision) of water, sanitation, and hygiene supplies for adolescent girls and boys
Menstrual Hygiene Management
Support for adolescent girls' menstrual hygiene
Behavioral:
Nutrition Behavior Change Intervention (BCI)
Changing the knowledge, attitudes, and practices of nutrition (including dietary diversity), IFA, deworming
MHM & WASH Behavior Change Intervention (BCI)
Changing the knowledge, attitudes, and practices of WASH and menstrual hygiene management

Locations

Country Name City State
Canada Nutrition International Ottawa Ontario

Sponsors (5)

Lead Sponsor Collaborator
Nutrition International CDC Foundation, Centers for Disease Control and Prevention, Directorate of Secondary and Higher Education, Ministry of Education, Bangladesh, Institute of Public Health and Nutrition, Ministry of Health and Family Welfare, Bangladesh

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hemoglobin concentration and anemia prevalence among adolescent girls Assessment of hemoglobin concentration and anemia prevalence among adolescent girls, using HemoCue® Hb-301 photometer Up to 12 months
Primary Iron and folate status, iron deficiency and folate insufficiency among adolescent girls a) Iron status and inflammation was assessed using a sandwich ELISA method, including 2 indicators of iron status (ferritin, sTfR) and 2 indicators of inflammation (C-reactive protein (CRP) and alpha 1-acid glycoprotein (AGP)); b) Folate status was assessed using a microbiological assay to test for red blood cell (RBC) folate and serum folate Up to 12 months
Primary Decrease morbidity among adolescents due to improved water, sanitation and hygiene (WASH) behaviour. Recall of morbidity symptoms over the past 3 days Up to 12 months
Primary Decrease barriers to menstrual hygiene management (MHM) for adolescent girls and thereby improve their school attendance In-school subsidized purchase of sanitary pads for menstruating girls Up to 12 months
See also
  Status Clinical Trial Phase
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03341338 - Genes-in-Action - Hepcidin Regulation of Iron Supplementation
Completed NCT00060398 - Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Phase 3
Recruiting NCT05384691 - Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions Phase 2
Not yet recruiting NCT06309641 - Methemoglobinemia Following Intravenous Iron Treatment
Completed NCT03822884 - Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers Phase 1
Completed NCT02912494 - A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT02912533 - A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02930850 - Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation N/A
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Completed NCT02603250 - Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda N/A
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Withdrawn NCT01934842 - A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate N/A
Completed NCT02310113 - Transfusion and Skeletal Muscle Tissue Oxygenation N/A
Completed NCT01922479 - Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure Phase 4
Completed NCT01693029 - Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Phase 3
Completed NCT01432717 - Study of ACE-536 in Healthy Postmenopausal Women Phase 1
Terminated NCT01535781 - Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced? N/A